(Q45059370)

9 December 2017

title

Autologous bone marrow transplantation for patients with relapsed hodgkin's disease (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

15 November 2022

author name string

J. O. Armitage

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750430

15 November 2022

P. J. Bierman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750430

15 November 2022

J. M. Vose

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750430

15 November 2022

J. R. Anderson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750430

15 November 2022

D. D. Weisenburger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750430

15 November 2022

A. Kessinger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750430

15 November 2022

E. C. Reed

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750430

15 November 2022

W. P. Vaughan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750430

15 November 2022

P. F. Coccia

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750430

15 November 2022

D. T. Purtilo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750430

15 November 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

full work available at URL

9 December 2017

https://api.elsevier.com/content/article/PII:000293439190213H?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

https://api.elsevier.com/content/article/PII:000293439190213H?httpAccept=text/plain

15 November 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

American Journal of Medicine

15 November 2022

published in

1 reference

9 December 2017

volume

91

1 reference

9 December 2017

issue

6

1 reference

9 December 2017

page(s)

605-611

1 reference

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

9 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Radiation therapy salvage of Hodgkin's disease following chemotherapy failure

15 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Radiotherapy with curative intent: an option in selected patients relapsing after chemotherapy for advanced Hodgkin's disease

15 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Prolonged Disease-Free Survival in Hodgkin's Disease with MOPP Reinduction After First Relapse

15 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease

15 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP)

15 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy

15 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease

15 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.

15 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease

15 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Exact significance testing to establish treatment equivalence with ordered categorical data

15 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Nonparametric Estimation from Incomplete Observations

15 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

15 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Bone marrow transplantation as salvage therapy in advanced Hodgkin's disease: allogeneic or autologous

15 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease

15 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease

15 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

15 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease

15 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease

15 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease

15 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease

15 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study

15 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Allogeneic marrow transplantation for refractory Hodgkin's disease

15 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

15 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Salvage Chemotherapy with ABVD in MOPP-Resistant Hodgkin's Disease

15 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Adriamycin combinations as salvage therapy in advanced MOPP-resistant Hodgkin's disease

15 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV)

15 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).

15 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90213-H

15 November 2022

Identifiers

1 reference

9 December 2017

1 reference